פאפאוורין טבע להזרקה
teva israel ltd - papaverine hydrochloride - תמיסה להזרקה - papaverine hydrochloride 40 mg / 2 ml - papaverine - papaverine - antispasmodic in visceral spasm, e.g. gastrointestinal colic, biliary and urinary tract spasms. peripheral vascular disease with vasospastic element. vascular spasm associated with acute myocardial infarcion, angina pectoris, peripheral and pulmonary embolism.
פפברין הידרוכלוריד 40 מג
rekah pharmaceutical industry ltd, israel - papaverine hydrochloride - טבליה - papaverine hydrochloride 40 mg - papaverine - papaverine - treatment of arterial spasm.
פאפאברין הידרוכלוריד 80 מג
rekah pharmaceutical industry ltd, israel - papaverine hydrochloride - טבליה - papaverine hydrochloride 80 mg - papaverine - papaverine - antispasmodic. vasodilator.
פפברין הידרוכלוריד סטרופ 40 מג 2 מל
raz pharmaceutics ltd, israel - papaverine hydrochloride - תמיסה להזרקה - papaverine hydrochloride 40 mg / 2 ml - papaverine
ספסמלגין
sam-on ltd - atropine sulfate; codeine phosphate; papaverine hydrochloride; paracetamol - טבליה - paracetamol 150 mg; atropine sulfate 0.4 mg; papaverine hydrochloride 80 mg; codeine phosphate 10 mg - paracetamol, combinations excl. psycholeptics - paracetamol, combinations excl. psycholeptics - analgesic and antispasmodic for the digestive system, the kidneys and the gall bladder.
טי.אר.ה.
ferring pharmaceuticals ltd - protirelin 0.2 mg/ml - solution for injection - tests for thyreoidea function - for monitoring the functional state of the hypothalamo- pituitary-thyroid axis.
סטאלבו 10025200 מג
inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.
סטאלבו 5012.5200 מג
inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.